Earnings History Data for CorMedix Inc. (CRMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CorMedix Inc.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. Defencath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product, which provides an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also intends to develop Defencath as a catheter lock solution for use in oncology and total parenteral nutrition patients. It is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with programs in surgical sutures and meshes, and topical hydrog
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-08-2021 AH 4:00 PM ET
(Aug 12)
CRMD CorMedix Inc. 228.70 -0.12 -0.18 -0.14 CorMedix EPS beats by $0.06, misses on revenue
[8/12/2021 4:10 PM]
6.35 0.40 
(6.72%)
6.01 0.06 
(1.01%)
3.86 - 18.80 394,314 210,000 953
13-05-2021 AH 4:05 PM ET
(May 13)
CRMD CorMedix Inc. 323.59 -0.20 -0.18 -0.21 CorMedix EPS misses by $0.02, beats on revenue
[5/13/2021 4:23 PM]
6.01 -1.55 
(-20.50%)
5.57 -1.99 
(-26.32%)
3.64 - 18.80 2,881,406 310,000 171,968
30-03-2021 AH 4:05 PM ET
(Mar 30)
CRMD CorMedix Inc. 274.73 -0.19 -0.23 -0.21 CorMedix EPS beats by $0.03, beats on revenue
[3/30/2021 4:07 PM]
10.00 1.01 
(11.23%)
8.70 -0.29 
(-3.23%)
3.00 - 18.80 923,816 590,000 2,685
05-11-2020 AH 4:05 PM ET
(Nov 5)
CRMD CorMedix Inc. 169.00 -0.22 -0.26 -0.22 CorMedix EPS beats by $0.04, beats on revenue
[11/5/2020 5:55 PM]
5.28 -0.10 
(-1.86%)
5.04 -0.34 
(-6.32%)
2.16 - 7.97 182,791 209,640 13,381
10-08-2020 AH 4:10 PM ET
(Aug 10)
CRMD CorMedix Inc. 114.44 -0.14 -0.24 -0.24 CorMedix EPS in-line, misses on revenue
[8/10/2020 4:28 PM]
4.19 -0.06 
(-1.41%)
4.20 -0.05 
(-1.18%)
2.16 - 8.64 253,833 749,293 1,662